Quarterly report pursuant to Section 13 or 15(d)

Equity Incentive Plans (Tables)

Equity Incentive Plans (Tables)

9 Months Ended

Sep. 30, 2022

Share-Based Payment Arrangement [Abstract]

A summary of option activities under the 2005 Stock Plan, as amended in January 2010 and November 2012 (the "2005 Plan") and 2017 Equity Incentive Plan (the “2017 Plan") during the nine months ended September 30, 2022 is as follows:


	Number of Options Outstanding			Weighted Average Exercise Price
Outstanding as of December 31, 2021		783,928		$	28.00
Granted		530,122		$	27.01
Exercised		(22,689	)	$	10.16
Canceled		(33,190	)	$	34.02
Outstanding as of September 30, 2022		1,258,171		$	27.73

Schedule of Outstanding Restricted Stock Units Awards Activity

A summary of restricted stock unit ("RSU") activities under the 2017 Plan during the nine months ended September 30, 2022 is as follows:


	Number of Restricted Stock Units			Weighted Average Grant Date Fair Value per RSU
Unvested awards outstanding as of December 31, 2021		128,810		$	35.09
Granted		198,192		$	26.58
Vested		(87,460	)	$	31.83
Canceled		(2,830	)	$	26.50
Unvested awards outstanding as of September 30, 2022		236,712		$	29.27

Schedule of Stock-Based Compensation Expense Recorded in Condensed Consolidated Statements of Operations

Total stock-based compensation expense associated with the 2005 Plan, 2017 Plan and 2017 ESPP is recorded in the condensed consolidated statements of operations and was allocated as follows (in thousands):


	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Cost of revenues	$	499	$	372	$	1,482	$	1,179
Sales and marketing		427		399		1,336		1,182
Research and development		305		181		823		543
General and administrative		926		501		2,504		1,418
Total	$	2,157	$	1,453	$	6,145	$	4,322